Evidence map›Paper›PMID 14551249›Full record

ArticleMolecular biology of the cell2003

Localization and dynamics of Cdc2-cyclin B during meiotic reinitiation in starfish oocytes.

Mark Terasaki, Ei-Ichi Okumura, Beth Hinkle, Takeo Kishimoto

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mark TerasakiDepartment of Physiology, University of Connecticut Health Center, Farmington, Connecticut 06032, USA. terasaki@neuron.uchc.edu
Ei-Ichi Okumura
Beth Hinkle
Takeo Kishimoto
Tokyo Institute of Technology · JPUConn Health · US

Funding

MECHANISMS OF NUCLEAR ENVELOPE BREAKDOWNR01GM060389 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI TERASAKI, MARK R · 2000 to 2004
$892k
NIGMS NIH HHS R01 GM060389NIGMS NIH HHS R01-GM60389
6 · The paper itself

Abstract

The Cdc2-cyclin B kinase has a central role in regulating the onset of M phase. In starfish oocytes, Cdc2-cyclin B begins to be activated approximately 10 min after application of maturation hormone, followed by accumulation in the nucleus then nuclear envelope breakdown. By immunofluorescence and by expressing a green fluorescent (GFP) chimera of cyclin B, we find that cyclin B is present in aggregates in the cytoplasm of immature oocytes. The aggregates disperse at approximately 10 min, suggesting that the dispersal is closely related to the activation of the kinase. Using cyclin B-GFP, the dispersion begins from the region containing the centrosomes. Extractability of Cdc2-cyclin B changes with similar kinetics during maturation. Active Cdc25 phosphatase released Cdc2-cyclin B from the detergent-insoluble fraction independently of its phosphatase activity. Live cell imaging also showed that Cdc2-cyclin B begins to accumulate in the nucleus before changes in nuclear pore permeability, consistent with Cdc2-cyclin B-induced disassembly of the pores.

Indexed as

Animalscdc25 PhosphatasesCDC2 Protein KinaseCell FractionationCell NucleusCyclin BCytoplasmGreen Fluorescent ProteinsLuminescent ProteinsMicroinjectionsMicroscopy, FluorescenceMitosisOocytesStarfishcdc25 PhosphatasesCDC2 Protein KinaseCyclin BGreen Fluorescent ProteinsLuminescent Proteins

Identifiers

PMID14551249
PMCPMC266783
OpenAlexW2147823651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.